Skip to main content

Many Primary Care Docs Unaware of Biologic Asthma Meds

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 21, 2023.

By Dennis Thompson HealthDay Reporter

TUESDAY, Nov. 21, 2023 -- Biologic drugs to treat asthma have been around for two decades, but a surprising number of family doctors still aren’t prescribing them to kids and adults.

A new survey found that more than two in five primary care docs (42%) are unfamiliar with asthma biologics, according to findings presented at this month's American College of Allergy, Asthma and Immunology annual meeting in Anaheim, Calif.

The doctors didn’t know the criteria for prescribing the drugs -- including essential lab work -- and often waited until a patient had experienced two or more asthma attacks in a year before referring them to an asthma specialist, the survey found.

“We know that many people who suffer from asthma are regularly seen by PCPs, and we wanted to know if PCPs were familiar with biologics to treat asthma,” said lead researcher Dr. Bijalben Patel, a resident at the University of South Florida (USF).

“We also wanted to explore at what point PCPs were referring asthma patients with uncontrolled symptoms to asthma specialists, and whether they were aware of eligibility requirements for a patient to start biologic treatment,” Patel added in a meeting news release.

The researchers surveyed 85 primary care physicians via e-mail, including internists, family medicine specialists and pediatricians.

They found that 82% do not get the labs needed to prescribe biologics, including 90% who do not test for absolute eosinophil count. Eosinophils are a type of white blood cell that are active in allergic conditions.

"The results of the survey point to the need to improve the communication between primary care physicians and asthma care specialists, including regarding use of biologics,” said senior researcher Dr. Juan Carlos Cardet, an associate professor of allergy and immunology at USF.

“Biologics have become an important tool in the treatment of asthma and other allergic diseases such as atopic dermatitis [eczema], chronic rhinosinusitis with nasal polyps and eosinophilic esophagitis, and can prevent substantial ill results from occurring in patients who are eligible for them,” Cardet added.

Sources

  • American College of Allergy, Asthma and Immunology, news release, Nov. 9, 2023

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted November 2023

Read this next

COVID Does Not Spur Asthma in Kids, Study Finds

WEDNESDAY, April 17, 2024 -- There’s no evidence that a COVID infection increases the risk of asthma in children, the first study to date on the subject finds. “We...

Planning Safe Summer Camp Fun for Kids With Allergies & Asthma

SATURDAY, April 13, 2023 -- Preparing a kid for summer camp is already a daunting task, and it’s even more complicated if your child has allergies or asthma, experts...

Researchers Find New Way to Curb Asthma Attacks

TUESDAY, March 26, 2025 -- A protein that shuts down immune cells in the lungs could be key to a new treatment for asthma attacks, a new report says. The naturally occurring...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.